GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Price-to-Operating-Cash-Flow
中文

CollPlant Biotechnologies (CollPlant Biotechnologies) Price-to-Operating-Cash-Flow : (As of Apr. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Price-to-Operating-Cash-Flow?

As of today (2024-04-25), CollPlant Biotechnologies's share price is $5.41. CollPlant Biotechnologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.24. Hence, CollPlant Biotechnologies's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for CollPlant Biotechnologies's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, CollPlant Biotechnologies's highest Price-to-Operating-Cash-Flow Ratio was 157.14. The lowest was 26.48. And the median was 67.41.

CLGN's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 24.92
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

CollPlant Biotechnologies's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $-0.21. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.24.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.80% per year.

During the past 12 years, CollPlant Biotechnologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 29.80% per year. The lowest was -256.90% per year. And the median was -20.65% per year.


CollPlant Biotechnologies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for CollPlant Biotechnologies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Price-to-Operating-Cash-Flow Chart

CollPlant Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 78.28 - -

CollPlant Biotechnologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CollPlant Biotechnologies's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, CollPlant Biotechnologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Price-to-Operating-Cash-Flow falls into.



CollPlant Biotechnologies Price-to-Operating-Cash-Flow Calculation

CollPlant Biotechnologies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=5.41/-0.237
=

CollPlant Biotechnologies's Share Price of today is $5.41.
CollPlant Biotechnologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

CollPlant Biotechnologies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

CollPlant Biotechnologies (CollPlant Biotechnologies) Headlines